A chance to end the global HIV epidemic: low-cost preventative drug to roll out on 2027

Generic variations of a groundbreaking injectable HIV-prevention drug must be out there for $40 a yr in additional than 100 international locations from 2027, in line with Unitaid and the Gates Basis. The 2 organisations have entered into separate agreements with Indian pharmaceutical corporations to provide cheaper generic variations of lenacapavir — a twice-yearly injection proven to cut back the chance of HIV transmission by greater than 99.9 p.c — for low- and middle-income international locations. Particulars by Unitaid government directorn Philippe Duneton.



Source link